Advertisement
Singapore markets open in 6 hours 9 minutes
  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • Dow

    39,118.86
    -45.24 (-0.12%)
     
  • Nasdaq

    17,732.60
    -126.10 (-0.71%)
     
  • Bitcoin USD

    61,856.76
    +950.74 (+1.56%)
     
  • CMC Crypto 200

    1,280.89
    -2.94 (-0.23%)
     
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • Gold

    2,336.90
    +0.30 (+0.01%)
     
  • Crude Oil

    81.46
    -0.28 (-0.34%)
     
  • 10-Yr Bond

    4.3430
    +0.0550 (+1.28%)
     
  • Nikkei

    39,583.08
    +241.58 (+0.61%)
     
  • Hang Seng

    17,718.61
    +2.11 (+0.01%)
     
  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     
  • Jakarta Composite Index

    7,063.58
    +95.63 (+1.37%)
     
  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

The Zacks Analyst Blog Highlights Roche, Wells Fargo, General Aerospace and Key Tronic

For Immediate Release

Chicago, IL – June 5, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Roche Holding AG RHHBY, Wells Fargo & Co. WFC, General Aerospace Co. GE and Key Tronic Corp. KTCC.

Here are highlights from Tuesday’s Analyst Blog:

Top Analyst Reports for Roche, Wells Fargo and GE Aerospace

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG, Wells Fargo & Co. and General Electric Co., as well as a micro-cap stock Key Tronic Corp. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.

These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today's research reports here >>>

Shares of Roche have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-17.4% vs. +28.9%). The company's performance has been negatively impacted by lower COVID-19-product-related sales. This, in turn, has significantly affected its top line, even though the diagnostics base business and newer drugs maintain growth.

The outlook for 2024 is ordinary as well. Competition from biosimilars for established cancer medicines like Avastin, MabThera/Rituxan and Herceptin also hurt sales, resulting in the stock's underperformance in the past year.

Nevertheless, Vabysmo, Ocrevus, Hemlibra and Polivy boost growth. Vabysmo has put up a stellar performance against Eylea. The company's efforts to develop new drugs to combat the decline in legacy drugs are encouraging. However, the approval of a higher dose of Eylea might pose challenges for Vabysmo.

(You can read the full research report on Roche here >>>)

Wells Fargo shares have outperformed the Zacks Banks - Major Regional industry over the past six months (+35.1% vs. +26.9%). The company's progress on efficiency initiatives, such as branch footprint reduction, will continue to support expense reduction and drive bottom-line growth.

However, the company's loan growth is likely to remain limited, as the asset cap remains in place until it complies fully with regulators' demands regarding operational risk management.

Likewise, lower originations because of high rates will limit mortgage banking income. But a decent deposit balance will keep supporting its financials, given the strength in the Consumer Banking and Lending segment. With robust capital position and ample liquidity, the company's capital-distribution activities seem sustainable. The stock has decent upside potential in the near term given its strong fundamentals.

(You can read the full research report on Wells Fargo here >>>)

Shares of GE Aerospace have outperformed the Zacks Transportation - Airline industry over the past six months (+69.7% vs. +37.5%). The company has been witnessing strength in its Aerospace business, driven by robust demand for commercial engines and services. Rising U.S. & international defense budgets, geopolitical tensions, positive airline & airframer dynamics and robust demand for commercial air travel augur well for the company.

It remains committed to making investments to boost growth and provide better services to its customers. Its portfolio reshaping actions are likely to unlock values for its shareholders.

GE Aerospace's shareholder-friendly policies are encouraging. For 2024, it expects organic revenues to grow by at least low-double-digit range from the year-ago levels. However, it has been dealing with high costs and expenses related to projects and restructuring activities.

(You can read the full research report on GE Aerospace here >>>)

Key Tronic's shares have gained +2.2% over the past six months against the Zacks Electronics - Miscellaneous Products industry's gain of +25.2%. This microcap company with market capitalization of $45.09 million has secured new programs across various industries, expanding its customer base and revenue streams. Its global footprint, particularly in Vietnam, supports growth and mitigates risk.

The company's financial position is strong, with increased cash reserves and significant debt reduction. A positive revenue outlook for the fourth quarter of fiscal 2024 enhances its value proposition. Favorable market trends and strategic adjustments position Key Tronic to benefit from on-shoring and near-shoring trends.

However, KTCC faces declining revenues, reduced profitability and covenant breaches, leading to increased interest rates. Despite inventory reductions, high levels and increased DSO strain cash flow. Geographic and operational risks, including restructuring in Mexico, pose challenges to financial stability.

(You can read the full research report on Key Tronic here >>>)

ADVERTISEMENT

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                       

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Wells Fargo & Company (WFC) : Free Stock Analysis Report

GE Aerospace (GE) : Free Stock Analysis Report

Roche Holding AG (RHHBY) : Free Stock Analysis Report

Key Tronic Corporation (KTCC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research